ILF3 contributes to the establishment of the antiviral type I interferon program.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
10 01 2020
Historique:
accepted: 04 11 2019
revised: 21 10 2019
received: 16 05 2019
pubmed: 9 11 2019
medline: 19 3 2020
entrez: 9 11 2019
Statut: ppublish

Résumé

Upon detection of viral infections, cells activate the expression of type I interferons (IFNs) and pro-inflammatory cytokines to control viral dissemination. As part of their antiviral response, cells also trigger the translational shutoff response which prevents translation of viral mRNAs and cellular mRNAs in a non-selective manner. Intriguingly, mRNAs encoding for antiviral factors bypass this translational shutoff, suggesting the presence of additional regulatory mechanisms enabling expression of the self-defence genes. Here, we identified the dsRNA binding protein ILF3 as an essential host factor required for efficient translation of the central antiviral cytokine, IFNB1, and a subset of interferon-stimulated genes. By combining polysome profiling and next-generation sequencing, ILF3 was also found to be necessary to establish the dsRNA-induced transcriptional and translational programs. We propose a central role for the host factor ILF3 in enhancing expression of the antiviral defence mRNAs in cellular conditions where cap-dependent translation is compromised.

Identifiants

pubmed: 31701124
pii: 5614571
doi: 10.1093/nar/gkz1060
pmc: PMC7145544
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
CCL5 protein, human 0
CXCL10 protein, human 0
Chemokine CCL5 0
Chemokine CXCL10 0
Cytokines 0
IFIT2 protein, human 0
IFIT3 protein, human 0
ILF3 protein, human 0
Intracellular Signaling Peptides and Proteins 0
Nuclear Factor 90 Proteins 0
RNA, Double-Stranded 0
RNA, Messenger 0
RNA, Viral 0
RNA-Binding Proteins 0
Receptors, Immunologic 0
Ubiquitins 0
ISG15 protein, human 60267-61-0
Interferon-beta 77238-31-4
RIGI protein, human EC 3.6.1.-
DEAD Box Protein 58 EC 3.6.4.13
Poly I-C O84C90HH2L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

116-129

Subventions

Organisme : Wellcome Trust
ID : 107665/Z/15/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nature. 2003 Dec 4;426(6966):579-84
pubmed: 14654845
Biochemistry. 2016 Feb 16;55(6):948-59
pubmed: 26795062
J Biol Chem. 1994 Aug 12;269(32):20682-90
pubmed: 8051169
Wiley Interdiscip Rev RNA. 2015 Mar-Apr;6(2):243-56
pubmed: 25327818
Nat Microbiol. 2016 Dec 05;2:16250
pubmed: 27918527
Cold Spring Harb Perspect Biol. 2019 Apr 1;11(4):
pubmed: 29959190
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Biol Chem. 2014 Jul 25;289(30):21163-80
pubmed: 24920670
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4808-13
pubmed: 18339807
EMBO J. 1998 Aug 3;17(15):4379-90
pubmed: 9687506
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
J Biol Chem. 1999 Jul 16;274(29):20432-7
pubmed: 10400669
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Nucleic Acids Res. 2012 Oct;40(18):9356-68
pubmed: 22833610
J Interferon Cytokine Res. 2011 Jan;31(1):49-57
pubmed: 21190483
Mol Cell. 2019 Sep 19;75(6):1218-1228.e6
pubmed: 31494033
Mol Cell Biol. 2002 Oct;22(19):6681-8
pubmed: 12215525
Proc Natl Acad Sci U S A. 1978 Mar;75(3):1121-5
pubmed: 274704
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4173-8
pubmed: 18337511
J Biol Chem. 2001 Aug 24;276(34):32300-12
pubmed: 11438536
Noncoding RNA. 2019 Mar 22;5(1):
pubmed: 30909383
Mol Cell. 2019 Sep 19;75(6):1203-1217.e5
pubmed: 31494035
Nucleic Acids Res. 2008 Jun;36(11):3707-15
pubmed: 18480124
Mol Cell Biol. 2008 Jul;28(14):4629-41
pubmed: 18458058
Biochimie. 2015 Jan;108:20-4
pubmed: 25447144
Genes Dev. 2010 Dec 1;24(23):2640-53
pubmed: 21123651
J Biol Chem. 2007 Jan 19;282(3):1757-68
pubmed: 17114181
RNA. 2007 Oct;13(10):1675-92
pubmed: 17684232
Immunity. 2000 Jul;13(1):129-41
pubmed: 10933401
Nature. 2017 Jul 6;547(7661):114-117
pubmed: 28658212
Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6
pubmed: 23203888
J Immunol. 2014 Apr 15;192(8):3753-64
pubmed: 24623135
Mol Cell. 2017 Jul 20;67(2):214-227.e7
pubmed: 28625552
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4713-7
pubmed: 7515177
Science. 2016 Jan 15;351(6270):
pubmed: 26816383
Nucleic Acids Res. 2010 Jan;38(Database issue):D131-6
pubmed: 19917642
Cell Rep. 2018 Jun 12;23(11):3275-3285
pubmed: 29898398
Bioinformatics. 2019 Sep 1;35(17):3206-3207
pubmed: 30668641
EMBO J. 2003 Nov 3;22(21):5655-65
pubmed: 14592965
Retrovirology. 2006 Nov 24;3:83
pubmed: 17125513
Cell. 1990 Jul 27;62(2):379-90
pubmed: 1695551
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12097-102
pubmed: 19574459
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
Elife. 2019 Apr 23;8:
pubmed: 31012846
FEBS Lett. 2015 Jun 22;589(14):1539-45
pubmed: 25979169
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7729-33
pubmed: 1679235
Nucleic Acids Res. 2010 Jan;38(1):225-38
pubmed: 19850717
Nature. 1999 Jan 21;397(6716):271-4
pubmed: 9930704
Bioinformatics. 2012 Dec 1;28(23):3163-5
pubmed: 23023984
Commun Biol. 2019 Jan 14;2:19
pubmed: 30652130
Immunol Cell Biol. 2014 Sep;92(8):671-8
pubmed: 24839978
Biochim Biophys Acta. 2015 Jul;1849(7):801-11
pubmed: 25234618
Nucleic Acids Res. 2016 Feb 29;44(4):1924-36
pubmed: 26712564
Elife. 2016 Jan 06;5:
pubmed: 26735365
Retrovirology. 2007 Jun 12;4:41
pubmed: 17565699
Cell. 1994 May 6;77(3):391-400
pubmed: 8181059

Auteurs

Samir F Watson (SF)

Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK.

Nicolas Bellora (N)

IPATEC, CONICET, Bariloche, Argentina.

Sara Macias (S)

Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, King's Buildings, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH